Analysis of data from The Cancer Genome Atlas (TCGA) identified that high PDCD1LG2 expression was associated with reduced overall and cancer-specific survival in patients with PDAC (Fig. 2a). This evidence concerns the gene PDCD1LG2 and cancer.